Exact Sciences Announces Cologuard Will Now Be Available By Prescription Through MDVIP Physicians

BOCA RATON, Fla. & MADISON, Wis.--(BUSINESS WIRE)-- MDVIP, the leader in personalized preventive medicine with a nationwide network of over 750 affiliated primary care physicians, announced today that Cologuard®, the first and only Food and Drug Administration (FDA) approved, noninvasive stool DNA screening test for colorectal cancer will now be available by prescription through its physicians. MDVIP is the first personalized healthcare network to partner with Exact Sciences to bring this innovative new test to its primary care physicians.

"MDVIP physicians have traditionally been early adopters of medical innovation," says Dr. Andrea Klemes, Chief Medical Officer of MDVIP. "Cologuard, a significant advancement in colorectal cancer detection, will allow our patients who are 50 years and older and at average risk for colorectal cancer, an easy to use screening test which they can do in the privacy of their own home."

Read More

Topics: Exact Sciences News